PDCD4 and breast cancer: MiR-21-5p has been previously reported to regulate chemosensitivity to classic BC treatment regimens by targeting tumor-suppressors such as PTEN and programmed Cell Death 4 (PDCD4) [51,52,53] in various cancers.